Jill Ann Howe

Director, BIORA THERAPEUTICS, INC.

Companies

Lineage Cell TherapeuticsChief financial officer Nov 16, 2022 to now¹
BIORA THERAPEUTICS, INC.Board member Nov 5, 2021 to Jun 6, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lineage Cell Therapeutics LCTX25,500 shares³$25.2K at $0.99Nov 26, 2024
BIORA THERAPEUTICS, INC.31,916 shares⁴Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 26, 2024Bought 15,000 shares at $0.59 of Lineage Cell Therapeutics³
Aug 16, 2024Bought 10,500 shares at $0.89 of Lineage Cell Therapeutics⁵
Jun 5, 2024Granted 12,500 shares of BIORA THERAPEUTICS, INC.⁴
Jun 14, 2023Granted 12,500 shares of BIORA THERAPEUTICS, INC.⁶
Jan 3, 2023Returned to company 19 shares of BIORA THERAPEUTICS, INC.⁷
Jun 15, 2022Granted 96,154 shares of BIORA THERAPEUTICS, INC.⁸
Nov 3, 2021Granted 76,754 shares of BIORA THERAPEUTICS, INC.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLineage Cell Therapeutics, Chief financial officer
2
SEC EDGARBIORA THERAPEUTICS, INC., Board member
3
SEC EDGARLineage Cell Therapeutics shares after the filing of Nov 26, 2024
4
SEC EDGARBIORA THERAPEUTICS, INC. shares after the filing of Jun 5, 2024
5
SEC EDGARForm 4 filed Aug 19, 2024
6
SEC EDGARForm 4 filed Jun 16, 2023
7
SEC EDGARForm 4 filed Jan 5, 2023
8
SEC EDGARForm 4 filed Jun 17, 2022
9
SEC EDGARForm 4 filed Nov 5, 2021